174 related articles for article (PubMed ID: 32457612)
1. Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer.
Reis MA; Matos AM; Duarte N; Ahmed OB; Ferreira RJ; Lage H; Ferreira MU
Front Pharmacol; 2020; 11():599. PubMed ID: 32457612
[TBL] [Abstract][Full Text] [Related]
2. Jatrophane diterpenes and cancer multidrug resistance - ABCB1 efflux modulation and selective cell death induction.
Reis MA; Ahmed OB; Spengler G; Molnár J; Lage H; Ferreira MJ
Phytomedicine; 2016 Aug; 23(9):968-78. PubMed ID: 27387405
[TBL] [Abstract][Full Text] [Related]
3. Exploring Jolkinol D Derivatives To Overcome Multidrug Resistance in Cancer.
Reis MA; Ahmed OB; Spengler G; Molnár J; Lage H; Ferreira MU
J Nat Prod; 2017 May; 80(5):1411-1420. PubMed ID: 28421773
[TBL] [Abstract][Full Text] [Related]
4. Triterpenoids from Momordica balsamina with a Collateral Sensitivity Effect for Tackling Multidrug Resistance in Cancer Cells.
Ramalhete C; Mulhovo S; Lage H; Ferreira MU
Planta Med; 2018 Dec; 84(18):1372-1379. PubMed ID: 29996165
[TBL] [Abstract][Full Text] [Related]
5. Macrocyclic diterpenes resensitizing multidrug resistant phenotypes.
Reis MA; Paterna A; Ferreira RJ; Lage H; Ferreira MJ
Bioorg Med Chem; 2014 Jul; 22(14):3696-702. PubMed ID: 24864039
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of terpenoids against classical and atypical multidrug resistant cancer cells.
Lage H; Duarte N; Coburger C; Hilgeroth A; Ferreira MJ
Phytomedicine; 2010 May; 17(6):441-8. PubMed ID: 19682879
[TBL] [Abstract][Full Text] [Related]
7. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
8. Improving the MDR reversal activity of 6,17-epoxylathyrane diterpenes.
Vieira C; Duarte N; Reis MA; Spengler G; Madureira AM; Molnár J; Ferreira MJ
Bioorg Med Chem; 2014 Nov; 22(22):6392-400. PubMed ID: 25438763
[TBL] [Abstract][Full Text] [Related]
9. Effective MDR reversers through phytochemical study of Euphorbia boetica.
Neto S; Duarte N; Pedro C; Spengler G; Molnár J; Ferreira MU
Phytochem Anal; 2019 Sep; 30(5):498-511. PubMed ID: 31218764
[TBL] [Abstract][Full Text] [Related]
10. High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs.
Lage H; Aki-Sener E; Yalcin I
Int J Cancer; 2006 Jul; 119(1):213-20. PubMed ID: 16450374
[TBL] [Abstract][Full Text] [Related]
11. New 6(17)-epoxylathyrane diterpene: aellinane from Euphorbia aellenii induces apoptosis via mitochondrial pathway in ovarian cancer cell line.
Nabatchian F; Moradi A; Aghaei M; Ghanadian M; Jafari SM; Tabesh S
Toxicol Mech Methods; 2017 Oct; 27(8):622-630. PubMed ID: 28651465
[TBL] [Abstract][Full Text] [Related]
12. Expression of genes and proteins of multidrug resistance in gastric cancer cells treated with resveratrol.
Mieszala K; Rudewicz M; Gomulkiewicz A; Ratajczak-Wielgomas K; Grzegrzolka J; Dziegiel P; Borska S
Oncol Lett; 2018 Apr; 15(4):5825-5832. PubMed ID: 29552213
[TBL] [Abstract][Full Text] [Related]
13. Selection and characterization of heat-resistant variants of multidrug-resistant human gastric carcinoma cell lines.
Jordan A; Scholz R
Exp Oncol; 2005 Mar; 27(1):18-23. PubMed ID: 15812352
[TBL] [Abstract][Full Text] [Related]
14. Improvement of cytotoxicity of mitoxantrone and daunorubicin by candidone, tephrosin, and bavachinin.
Darzi S; Mirzaei SA; Elahian F; Peymani A; Rahmani B; Pishkhan Dibazar S; Shirian S; Shakeri Chaleshtori L; Aali E
Mol Biol Rep; 2021 Nov; 48(11):7105-7111. PubMed ID: 34564803
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).
Nieth C; Priebsch A; Stege A; Lage H
FEBS Lett; 2003 Jun; 545(2-3):144-50. PubMed ID: 12804765
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antiproliferative and anti-MDR activities of lathyrane diterpene derivatives based on configuration inversion strategy.
Xiao Y; Ji WS; Jin WK; Wen P; Shan LH; Hou ZR; Li XH; Zhou XL; Liu YJ; Xu JB; Gao F
Bioorg Chem; 2023 Feb; 131():106329. PubMed ID: 36565674
[TBL] [Abstract][Full Text] [Related]
17. Phenolic compounds as selective antineoplasic agents against multidrug-resistant human cancer cells.
Duarte N; Lage H; Abrantes M; Ferreira MJ
Planta Med; 2010 Jul; 76(10):975-80. PubMed ID: 20157880
[TBL] [Abstract][Full Text] [Related]
18. Enhancing lathyrane structural diversity and MDR activity by combinatorial modification of lathyrane nucleus and ester side chain: A case study of Euphorbia Factor L1 and Euphorbia Factor L3.
Zhan Z; Liu X; Cheng Z
Fitoterapia; 2024 Apr; 174():105854. PubMed ID: 38331050
[TBL] [Abstract][Full Text] [Related]
19. Valproate modulates the activity of multidrug resistance efflux pumps, as a chemoresistance factor in gastric cancer cells.
Hosseini SA; Mirzaei SA; Kermani S; Yaghoobi H
Mol Biol Rep; 2024 Mar; 51(1):427. PubMed ID: 38498238
[TBL] [Abstract][Full Text] [Related]
20. Association of genomic imbalances with drug resistance and thermoresistance in human gastric carcinoma cells.
Tönnies H; Poland J; Sinha P; Lage H
Int J Cancer; 2003 Mar; 103(6):752-8. PubMed ID: 12516094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]